{
    "code": "52027514",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027514",
    "time": "2020-03-27 03:20:01",
    "許可證字號": "衛部藥輸字第027514號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/10\/25",
    "發證日期": "107\/10\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202751402",
    "中文品名": "滋若愷膜衣錠",
    "英文品名": "JULUCA film coated tablets",
    "適應症": "適用於符合以下所有情況的人類免疫不全病毒-1 (HIV-1)感染症成人病人，替代其現行全部抗反轉錄病毒處方治療：(1)現行抗反轉錄病毒處方治療劑量維持穩定且達到病毒學抑制效果(HIV-1 RNA",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新複方",
    "監視期限": "112\/10\/25",
    "主成分略述": "RILPIVIRINE HYDROCHLORIDE, Dolutegravir Sodium",
    "限制項目": "02輸　入",
    "申請商名稱": "6201011338  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "臺北市中正區忠孝西路一段66號23、24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGB0044000  GLAXO OPERATIONS UK LIMITED",
            "製造廠廠址": "PRIORY STREET,WARE,HERTFORDSHIRE SG12 0DJ,UNITED KINGDOM.",
            "製造廠公司地址": "-",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FES0122000  GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, ARANDA de DUERO, BURGOS 09400, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "包裝及分裝"
        },
        {
            "製造廠名稱": "FGB0290000  VIIV HEALTHCARE UK LIMITED",
            "製造廠廠址": "980 GREAT WEST ROAD BRENTFORD MIDDLESEX, TW8 9GS, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818004700",
            "成分名稱": "Dolutegravir Sodium",
            "含量描述": "(equivalent to 50 mg dolutegravir free acid)",
            "含量": "52.6200000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818004310",
            "成分名稱": "RILPIVIRINE HYDROCHLORIDE",
            "含量描述": "(equivalent to 25 mg rilpivirine free base)",
            "含量": "27.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部藥輸字第027514號仿單-107-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027514&Seq=001&Type=9"
        },
        {
            "title": "紙盒-107-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027514&Seq=002&Type=8"
        },
        {
            "title": "標籤-107-11-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027514&Seq=001&Type=8"
        }
    ]
}